绝经后女性使用雌激素和孕激素与患乳腺癌风险。G.A. 科尔迪茨等人。《新英格兰医学杂志》1995年；332卷：1589 - 1593页。 - Suppr

Suppr

超能文献

The use of oestrogens and progestin and the risk of breast cancer in post-menopausal women. G.A. Colditz et al. N. Engl. J. Med. 1995; 332: 1589-93.

作者信息

Kauppila A

机构信息

Department of Obstetrics and Gynecology, University of Oulu, Finland.

出版信息

Pharmacol Res. 1995 Dec;32(6):327. doi: 10.1016/s1043-6618(05)80035-0.

DOI:10.1016/s1043-6618(05)80035-0

PMID:8736481

Abstract

摘要

相似文献

The use of oestrogens and progestin and the risk of breast cancer in post-menopausal women. G.A. Colditz et al. N. Engl. J. Med. 1995; 332: 1589-93.绝经后女性使用雌激素和孕激素与患乳腺癌风险。G.A. 科尔迪茨等人。《新英格兰医学杂志》1995年；332卷：1589 - 1593页。

Pharmacol Res. 1995 Dec;32(6):327. doi: 10.1016/s1043-6618(05)80035-0.

Critical review of the article by Colditz et al. on 'The use of estrogens and progestins and the risk of breast cancer in postmenopausal women' published in the N.E.J.M. 1995, 332: 1589.对科尔迪茨等人发表于《新英格兰医学杂志》1995年第332卷第1589页上的文章《绝经后妇女使用雌激素和孕激素与患乳腺癌风险》的批判性综述。

Pharmacol Res. 1995 Dec;32(6):329-30. doi: 10.1016/s1043-6618(05)80036-2.

Oestrogens and progestins and breast cancer risk in post-menopausal women.雌激素和孕激素与绝经后女性患乳腺癌的风险

Pharmacol Res. 1995 Dec;32(6):323-4. doi: 10.1016/s1043-6618(05)80033-7.

The use of estrogens and progestins and the risk of breast cancer in postmenopausal women.绝经后女性使用雌激素和孕激素与患乳腺癌风险

N Engl J Med. 1995 Jun 15;332(24):1589-93. doi: 10.1056/NEJM199506153322401.

Does post-menopausal hormone-replacement therapy increase risk for breast cancer? A perspective on the findings of the Nurses' Health Study.

Pharmacol Res. 1995 Dec;32(6):331-3. doi: 10.1016/s1043-6618(05)80037-4.

Estrogen, estrogen plus progestin therapy, and risk of breast cancer.雌激素、雌激素加孕激素疗法与乳腺癌风险

Clin Cancer Res. 2005 Jan 15;11(2 Pt 2):909s-17s.

Combined estrogen and progestin hormone replacement therapy in relation to risk of breast cancer in middle-aged women.中年女性联合雌激素和孕激素激素替代疗法与乳腺癌风险的关系

JAMA. 1995 Jul 12;274(2):137-42.

Re: effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin.关于：激素替代疗法对乳腺癌风险的影响：雌激素与雌激素加孕激素对比

J Natl Cancer Inst. 2000 Dec 6;92(23):1950-2. doi: 10.1093/jnci/92.23.1950.

Re: Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin.回复：激素替代疗法对乳腺癌风险的影响：雌激素与雌激素加孕激素的对比

J Natl Cancer Inst. 2000 Jul 5;92(13):1100-1. doi: 10.1093/jnci/92.13.1100.

Estrogen and estrogen-progestin replacement therapy and risk of postmenopausal breast cancer in Canada.雌激素和雌激素 - 孕激素替代疗法与加拿大绝经后乳腺癌风险

Cancer Causes Control. 2002 Aug;13(6):583-90. doi: 10.1023/a:1016330024268.

引用本文的文献

[Perianal Fistula: An Overview].[肛周瘘管：概述]

J Korean Soc Radiol. 2023 May;84(3):565-585. doi: 10.3348/jksr.2023.0018. Epub 2023 May 30.

Preventive effects of kudzu root on bone loss and cartilage degradation in ovariectomized rats [corrected].葛根对去卵巢大鼠骨质流失和软骨降解的预防作用[校正后]

Am J Transl Res. 2017 Jul 15;9(7):3517-3527. eCollection 2017.

The expression of syndecan-1, syndecan-4 and decorin in healthy human breast tissue during the menstrual cycle.黏附素-1、黏附素-4 和核心蛋白聚糖在月经周期中健康人乳腺组织中的表达。

Reprod Biol Endocrinol. 2010 Apr 16;8:35. doi: 10.1186/1477-7827-8-35.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验